Assignee
ADVERIO PHARMA GMBH
DE·19 granted patents·4 pending applications·40 citations·filing 2014–2024
Top patents by PatentIndex Score
23 records- 0196US9993476B2Substituted 5-flouro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2016·Granted Jun 12, 2018·16 cites·13 claims
- 0295US11439642B2Substituted 5-fluoro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2020·Granted Sep 13, 2022·3 cites·66 claims
- 0393US9604948B2Process for preparing substituted 5-fluoro-1H-pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2015·Granted Mar 28, 2017·5 cites·8 claims
- 0491US11203593B2Forms of methyl {4,6-diamino-2-[1(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamateADVERIO PHARMA GMBH·Filed 2020·Granted Dec 21, 2021·2 cites·22 claims
- 0590US9845300B2Process for preparing substituted 5-fluoro-1H-pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2017·Granted Dec 19, 2017·3 cites·1 claims
- 0689US10736896B2Substituted 5-fluoro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2018·Granted Aug 11, 2020·2 cites·7 claims
- 0789US10351562B2Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compoundADVERIO PHARMA GMBH·Filed 2018·Granted Jul 16, 2019·6 cites·9 claims
- 0886US12064429B2Substituted 5-fluoro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2022·Granted Aug 20, 2024·0 cites·18 claims
- 0980US10633356B2Hydrates of substituted 5-fluoro-1H-pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2019·Granted Apr 28, 2020·0 cites·12 claims
- 1079US12503469B2Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamateADVERIO PHARMA GMBH·Filed 2021·Granted Dec 23, 2025·0 cites·5 claims
- 1178US10030014B2Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compoundADVERIO PHARMA GMBH·Filed 2014·Granted Jul 24, 2018·2 cites·5 claims
- 1277US10087183B2Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamateADVERIO PHARMA GMBH·Filed 2017·Granted Oct 2, 2018·1 cites·30 claims
- 1371US10633357B2Intermediates and process for preparing intermediates in the production of substituted pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2019·Granted Apr 28, 2020·0 cites·3 claims
- 1470US2025205235A1Dose regimen for vericiguatADVERIO PHARMA GMBH·Filed 2024·Application pending·0 cites
- 1569US10570130B2Process for preparing methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compoundADVERIO PHARMA GMBH·Filed 2019·Granted Feb 25, 2020·0 cites·2 claims
- 1669US10364229B2Crystalline substituted 5-fluoro-1H-pyrazolopyridines and process for preparingADVERIO PHARMA GMBH·Filed 2017·Granted Jul 30, 2019·0 cites·3 claims
- 1766US10662188B2Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamateADVERIO PHARMA GMBH·Filed 2018·Granted May 26, 2020·0 cites·30 claims
- 1860US2016129004A1Substituted 5-fluoro-1h-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2016·Application pending·0 cites
- 1947US11508483B2Method of identifying a subgroup of patients suffering from dcSSc which benefits from a treatment with sGC stimulators and sGC activators in a higher degree than a control groupADVERIO PHARMA GMBH·Filed 2019·Granted Nov 22, 2022·0 cites·10 claims
- 2046US2023219952A1Process for preparing methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3 -yl]pyrimidin-5-yl} carbamateADVERIO PHARMA GMBH·Filed 2021·Application pending·0 cites
- 2145US11760737B2Process for manufacturing 4-(2,2,3,3-tetrafluoropropyl)morpholineADVERIO PHARMA GMBH·Filed 2020·Granted Sep 19, 2023·0 cites·10 claims
- 2242US2023067593A1Nanoformulations of methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3 -yl]pyrimidin-5-yl} carbamateADVERIO PHARMA GMBH·Filed 2021·Application pending·0 cites
- 2338US12172996B2Methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate active compound product having improved properties, production and formulation thereofADVERIO PHARMA GMBH·Filed 2019·Granted Dec 24, 2024·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when ADVERIO PHARMA GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →